5,6-dihydro-5-azacytidine has been researched along with Malignant Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbasi, MM; Beisler, JA; Driscoll, JS; Kelley, JA | 1 |
Creagan, ET; Hartmann, LC; Loprinzi, CL; Schaid, DJ | 1 |
1 trial(s) available for 5,6-dihydro-5-azacytidine and Malignant Melanoma
Article | Year |
---|---|
A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Biopsy; Chest Pain; Female; Humans; Immunologic Factors; Infusions, Intravenous; Male; Melanoma; Middle Aged; Nausea; Remission Induction; Risk Factors; Severity of Illness Index; Survival Rate; Vomiting | 1993 |
1 other study(ies) available for 5,6-dihydro-5-azacytidine and Malignant Melanoma
Article | Year |
---|---|
Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine.
Topics: Animals; Antineoplastic Agents; Azacitidine; Hydrolysis; Leukemia L1210; Leukemia, Experimental; Melanoma; Mice; Neoplasms, Experimental | 1977 |